|Bid||0.00 x 900|
|Ask||0.00 x 1100|
|Day's Range||105.13 - 107.75|
|52 Week Range||93.25 - 142.60|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||33.02|
|Forward Dividend & Yield||1.88 (1.92%)|
|Ex-Dividend Date||Oct 13, 2022|
|1y Target Est||N/A|
Abbott (NYSE: ABT) has been recognized by the Consumer Technology Association (CTA) with three CES 2023 Innovation Awards for its life-changing technologies that are advancing the health tech industry and improving the lives of people worldwide. The CTA is the organization behind the Consumer Electronics Show (CES), the most influential technology event in the world.
Abbott recently released two overview reports - its 2021 Global Sustainability Summary Report and 2021 Diversity, Equity and Inclusion (DEI) Report - highlighting efforts to help the greatest number of people to live better, healthier lives.
CECP's CEO Investor Forum, the only platform that brings CEOs and investors together to discuss Long-Term Plans, hosted three CEOs from the world's largest medtech companies-Abbott (NYSE:ABT), Medtronic (NYSE:MDT), and Intuitive Surgical (NASDAQ:ISRG).